Association of E-cadherin gene 3′-UTR C/T polymorphism with primary open angle glaucoma

Ophthalmic Research

Volumn 38, Issue 1, 2005, Pages 44-48

  Lin, Hui Ju ^a,b   Tsai, Fuu Jen ^a   Hung, Porting ^a   Chen, Wen Chi ^a   Chen, Huey Yi ^a   Fan, Seng Sheen ^b   Tsai, Shih Wei ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; E cadherin; Metalloproteinases; Polymerase chain reaction; Primary open angle glaucoma

Indexed keywords

ADENINE NUCLEOTIDE; PYRIMIDINE NUCLEOTIDE; UVOMORULIN;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ANAMNESIS; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; EYE DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OPEN ANGLE GLAUCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS; VISUAL SYSTEM EXAMINATION;

3' UNTRANSLATED REGIONS; ADULT; AGED; BASE SEQUENCE; CADHERINS; CASE-CONTROL STUDIES; CYTOSINE; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; THYMINE;

EID: 29144489409     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089523     Document Type: Article

References (25)

1. Drance SM, Schulzer M, Thomas B, et al: Multivariate analysis in glaucoma use of discriminant analysis in predicating glaucomatous visual field damage. Arch Ophthalmol 1981;6:1019-1022.
2. Laske MC, Connell AMS, Wu S, et al: Risk factor of open-angle glaucoma. Arch Ophthalmol 1995;113:918-924.
3. Lin HJ, Tsai FJ, Chen WC, et al: Association of tumor necrosis factor alpha-308 gene polymorphism with primary open angle glaucoma in Chinese. Eye 2003;17:31-34.
4. Lin HJ, Tsai SC, Tsai FJ, et al: Association of interleukin-1beta and receptor antagonist gene polymorphisms with primary open angle glaucoma. Ophthalmologica 2003;217:358-364.
5. Camras CB, Alm A, Watson P, Stjernschantz J: Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology 1996;103:1916-1924.
6. Kuniyasu H, Ellis LM, Evans DB, et al: Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res 1999;5:25-33.
7. Nawrocki-Raby B, Gilles C, Polette M, et al: E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol 2003;163:653-661.
8. Streuli CH, Bailey N, Bissell MJ: Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression on the absence of cell-cell interaction and morphological polarity. J Cell Biol 1991;115:1383-1395.
9. Yap AS: The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Invest 1998;16:252-261.
10. Steinhusen U, Weiske J, Badock V, et al: Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 2001;276:4972-4980.
11. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-1455.
12. Gumbiner BM: Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-357.
13. Shapiro L, Fannon AM, Kwong PD, et al: Structural basis of cell-cell adhesion by cadherins. Nature 1995;374:327-337.
14. Huber O, Bierkamp C, Kemler R: Cadherins and catenins in development. Curr Opin Cell Biol 1996;8:685-691.
15. Vleminckx K, Kemler R: Cadherins and tissue formation: Integrating adhesion and signaling. Bioessays 1999;21:211-220.
16. La Rosa, Francis A, Lee David A: Collagen degradation in glaucoma: Will it gain a therapeutic value? Curr Opin Ophthalmol 2000;11:90-93.
17. Ando H, Twining SS, Yue BY, et al: MMPs and proteinase inhibtors in the human aqueous humor. Invest Ophthalmol Vis Sci 1993;343541-343548.
18. Samples JR, Alexander JP, Acott TS: Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone Invest Ophthalmol Vis Sci 1993;34:3386-3395.
19. Yan X, Tezel G, Wax MB, et al: Matrix metalloproteinases and tumor necrosis factor α in glaucomatous optic nerve head. Arch Ophthalnol 200;118:666-673.
20. Moll R, Mitze M, Frixen UH, et al: Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993;143:1731-1742.
21. Berx G, Cleton-Jansen A-M, Nollet F, et al: E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancer. EMBO J 1995;14:6107-6115.
22. Bscker KF, Reich U, Schott C, Hufler H: Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 1995;96:739-740.
23. Keirsebilck A, Van Hoorde L, Gao Y, et al: Mechanisms of downregulation of transfected E-cadherin cDNA during formation of invasive tumors in syngeneic mice. Invasion Metastais 1998;18:44-56.
24. Fu L, Benchimol S: Participation of the human p53 3′UTR in translational repression and activation following γ-irradiation. EMBO J 1997;16:4117-4725.
25. +/glucose cotransporter (SGLT1) mRNA stability. Interaction of a nucleocytoplamic protein with a regulatory domain in the 3′-untranslated region critical for stabilization. J Biol Chem 2000;275:33998-34008.